Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 12:13 AM
NCT ID:
NCT06697158
Eligibility Criteria:
Inclusion Criteria:
* Participants must be aged between 18 or 85 years,
* with a diagnosis of unilateral lymphedema in the upper extremity following breast cancer surgery
* stage 2 lymphedema confirmed by a doctor
* voluntary consent to participate in the study.
Exclusion Criteria:
* refusal to participate in the study
* development of lymphedema due to primary causes, presence of bilateral upper extremity lymphedema
* active soft tissue infection in the lymphedematous arm
* mental or cognitive disorders
* inability to communicate or cooperate
* acute deep vein thrombosis, arterial insufficiency in the upper extremity, systemic diseases that could cause edema other than lymphedema (e.g., renal failure, liver failure, heart failure)
* use of sleep medications or antidepressants
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT06697158
Study Brief:
Protocol Section:
NCT06697158